window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Biotech,Drug Development,Immunology,Research & Development

    Nucleome Therapeutics nominates first preclinical development candidate for inflammatory diseases

    Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

    January 8, 2026
  • Biomanufacturing,Cell & Gene Therapy,Research & Development,Technology and platforms

    FUJIFILM Biosciences unveils new name and broad life sciences focus

    FUJIFILM Irvine Scientific has officially rebranded as FUJIFILM Biosciences, signalling [...]

    January 5, 2026
  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Nanexa and Moderna sign licence and option agreement for Pharmashell drug delivery development

    Nanexa has entered into a licence and option agreement with [...]

    December 12, 2025
  • Biotech,Global health,Research & Development,Technology and platforms

    ICON 2025 global biotech survey shows China leading innovation and highlights Western opportunities

    ICON plc has released findings from its 2025 global biotech [...]

    December 11, 2025
  • Clinical studies,Clinical Trials,Oncology,Research & Development

    Vortex launches clinical study using liquid biopsy technology to advance cancer monitoring

      Vortex Liquid Biopsy Solutions has launched a clinical study [...]

    December 8, 2025
  • Clinical Development,Clinical studies,Research & Development

    Orano Med and Roche move two-step 212Pb therapy into clinical development

    Orano Med has advanced its long-running collaboration with Roche as [...]

    December 4, 2025
  • Artificial Intelligence,Clinical Development,Data Management,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Pistoia Alliance warns of scientific content crisis limiting accuracy of AI in life sciences R&D

    The Pistoia Alliance has reported new findings pointing to a [...]

    December 3, 2025
  • Clinical Trials,Oncology,Research & Development

    €1 million investment for BiPER Therapeutics to launch BPR001-615 BiP inhibitor trial

    BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

    December 2, 2025
  • Clinical Trials,Oncology,Research & Development

    One-carbon Therapeutics secures SEK 153 million (€13.9 million) to expand Odin trial

    One-carbon Therapeutics has secured SEK 153 million (€13.9 million) in [...]

    December 2, 2025
  • Central Nervous System,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme

    CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

    November 25, 2025
Previous111213Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech, Clinical Development, Clinical Trials, Healthcare leadership, Immunology, Movers & Shakers
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Artificial Intelligence, Clinical studies, Drug discovery, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top